Susquehanna International Group’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Susquehanna International Group’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,400	Closed	-$46.4K	–	13279
2024 Q2	$46.4K	Sell	22,400 -33,100	-60%	-$78K	﹤0.01%	11444
2024 Q1	$203K	Buy	55,500 +16,700	+43%	+$64K	﹤0.01%	10572
2023 Q4	$117K	Buy	38,800 +21,900	+130%	+$44.4K	﹤0.01%	11203
2023 Q3	$36.3K	Buy	16,900 +5,600	+50%	+$22.4K	﹤0.01%	11419
2023 Q2	$63.3K	Sell	11,300 -6,700	-37%	-$52.4K	﹤0.01%	11229
2023 Q1	$109K	Sell	18,000 -15,400	-46%	-$107K	﹤0.01%	11228
2022 Q4	$191K	Buy	33,400 +16,900	+102%	+$94.9K	﹤0.01%	10197
2022 Q3	$89K	Buy	+16,500	New	+$83.6K	﹤0.01%	11797

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Susquehanna International Group's OMGA Position: Q3 2024 in Review

Susquehanna International Group sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2024, closing a stake of 55,322 shares — an estimated $88.1K sold.

Susquehanna International Group first reported a position in OMGA in Q4 2021 and held it in 11 quarters. The position peaked at $1.17M in Q1 2023. 54 funds tracked by Wall St. Rank hold OMGA as of Q3 2024.

Susquehanna International Group reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 55,322 Omega Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $88.1K.
Susquehanna International Group first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Susquehanna International Group's Omega Therapeutics, Inc. Common Stock position peaked at $1.17M in Q1 2023.
54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.